FindTrial
Sign In

Clinical study of hemoperfusion in patients with toxic substances on toxic rodenticide poisoning

Clinical study of hemoperfusion in patients with toxic substances on toxic rodenticide poisoning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17014049
Enrollment
Unknown
Registered
2017-12-20
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Toxic rodenticide poisoning

Interventions

treatment group:Hemoperfusion

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Oral toxic rodenticide poisoning patients

Exclusion criteria

Exclusion criteria: Other causes of poisoning

Design outcomes

Primary

MeasureTime frame
Blood poison concentration;—

Countries

China

Contacts

Public ContactJian Xiangdong
jianxiangdongvip@163.com+86 18560083182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026